Counseling on vaginal delivery of contraceptive hormones: implications for women’s body knowledge and sexual health

Abstract Background: Healthcare providers (HCPs) have an important role in helping women select the contraceptive method that best matches their needs and lifestyle. Recent surveys outline the need of women to be informed about all available choices, including the newest methods (particularly those not requiring daily administration), such as vaginal contraception. Methods: The most relevant publications on combined contraceptive vaginal ring are revised in the context of counseling as an opportunity to empower women in term of vaginal health and sexual functioning. Results: HCPs should explain the main characteristics of the combined contraceptive vaginal ring including the anatomical and physiological implications that make the vagina an ideal route of hormonal administration and the basic notions about functional modifications of the vagina during reproductive life. Clinical data on the vaginal ring should be summarized with regard to efficacy, tolerability, pharmacokinetics, cycle control and user acceptability, including recent findings on extra-contraceptive benefits (also compared to other hormonal contraceptives) on the vaginal flora and on sexual function. Conclusion: Vaginal contraception offers various benefits and should always be discussed during contraceptive counseling. An open dialogue about vaginal contraception will also help enhance body knowledge and sexual health.

[1]  J. M. Marín,et al.  Vaginal health in contraceptive vaginal ring users – A review , 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[2]  L. Bahamondes,et al.  Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries. , 2012, Contraception.

[3]  D. Mishell,et al.  The contraceptive vaginal ring, NuvaRing®, a decade after its introduction , 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[4]  G. Stabile,et al.  Effects of hormonal contraception on vaginal flora. , 2012, Contraception.

[5]  L. Burrows,et al.  The effects of hormonal contraceptives on female sexuality: a review. , 2012, The journal of sexual medicine.

[6]  C. Grimm,et al.  Contraceptive counselling and factors affecting women's contraceptive choices: results of the CHOICE study in Austria. , 2012, Reproductive biomedicine online.

[7]  J. Menten,et al.  Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests , 2012, BMC Microbiology.

[8]  K. Rasinski,et al.  What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists. , 2012, The journal of sexual medicine.

[9]  I. Sinai,et al.  Contraceptive failure in the United States. , 2012, Contraception.

[10]  J. Bitzer,et al.  The CHOICE study: Effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries , 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[11]  J. Simon,et al.  Current issues and available options in combined hormonal contraception. , 2011, Contraception.

[12]  J. Fortenberry,et al.  Acceptability of the vaginal contraceptive ring among adolescent women. , 2010, Journal of pediatric and adolescent gynecology.

[13]  G. Merki-Feld,et al.  Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use , 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[14]  Lynn Pattimakiel,et al.  Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing®) , 2010, International journal of women's health.

[15]  A. Faúndes,et al.  Contraceptive vaginal rings: a review. , 2010, Contraception.

[16]  J. Peipert,et al.  Association Between Tampon Use and Choosing the Contraceptive Vaginal Ring , 2010, Obstetrics and gynecology.

[17]  K. Barnhart,et al.  Sexual function in first-time contraceptive ring and contraceptive patch users. , 2010, Fertility and sterility.

[18]  David J Hooper Attitudes, Awareness, Compliance and Preferences among Hormonal Contraception Users , 2010, Clinical drug investigation.

[19]  J. Trussell Understanding contraceptive failure. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[20]  R. Nappi,et al.  Psychosexual well-being in women using oral contraceptives containing drospirenone. , 2009, Functional neurology.

[21]  J. Higgins,et al.  Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women's Well-Being and Sexuality Study. , 2008, Sexual health.

[22]  F. Roumen Review of the combined contraceptive vaginal ring, NuvaRing® , 2008, Therapeutics and clinical risk management.

[23]  U. Karck,et al.  Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing®: Results of clinical experience in Germany , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[24]  M. Consolaro,et al.  Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). , 2007, Contraception.

[25]  J. Trussell,et al.  Contraceptive discontinuation attributed to method dissatisfaction in the United States. , 2007, Contraception.

[26]  I. Milsom,et al.  Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. , 2006, Contraception.

[27]  K. Rokstad,et al.  Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. , 2006, Human reproduction.

[28]  R. Cagiano,et al.  Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. , 2006, Contraception.

[29]  J. Shelton,et al.  Access to modern contraception. , 2006, Best practice & research. Clinical obstetrics & gynaecology.

[30]  R. Nappi,et al.  Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey. , 2006, Contraception.

[31]  F. Roumen,et al.  The combined contraceptive vaginal ring (NuvaRing®): First experience in daily clinical practice in The Netherlands , 2006, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[32]  I. Victor,et al.  Comparing Patient Telephone Callback Rates for Different Hormonal Birth Control Delivery Systems , 2005, American journal of therapeutics.

[33]  M. W. van den Heuvel,et al.  Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. , 2005, Contraception.

[34]  M. Guida,et al.  Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners. , 2005, Human reproduction.

[35]  N. R. de Melo,et al.  Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. , 2005, Contraception.

[36]  N. R. de Melo,et al.  Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. , 2005, Human reproduction.

[37]  P. V. D. van de Weijer What women want and what their doctors need – how do women evaluate the quality of contraceptive methods and products introduced by their gynaecologist? A different perspective , 2005, European journal of contraception & reproductive health care.

[38]  A. Salonia,et al.  Clinical biologic pathophysiologies of women's sexual dysfunction. , 2005, The journal of sexual medicine.

[39]  H. Maibach,et al.  Lifetime changes in the vulva and vagina , 2005, Archives of Gynecology and Obstetrics.

[40]  B. Burington,et al.  A Comparison Between the Vaginal Ring and Oral Contraceptives , 2004, Obstetrics and gynecology.

[41]  U. Karck,et al.  Why consider vaginal drug administration? , 2004, Fertility and sterility.

[42]  C. Loge,et al.  The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. , 2003, Contraception.

[43]  K. Lohr,et al.  Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda. , 2003, Contraception.

[44]  F. Roumen Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing , 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[45]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[46]  M. Tuppurainen,et al.  Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. , 2002, American journal of obstetrics and gynecology.

[47]  S. Sanders,et al.  A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. , 2001, Contraception.

[48]  A. Meier,et al.  Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. , 2000, Contraception.

[49]  B J Oddens,et al.  Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. , 1999, Contraception.

[50]  M S Waugh,et al.  Causes and consequences of oral contraceptive noncompliance. , 1999, American journal of obstetrics and gynecology.

[51]  G. Bachmann,et al.  Brief sexual inquiry in gynecologic practice. , 1989, Obstetrics and gynecology.

[52]  S. Rowlands Contraception Today , 1971, Practitioner.

[53]  D. Mishell,et al.  Contraceptive effect of varying dosages of progestogen in silastic vaginal rings. , 1970, Fertility and sterility.